Gheuens Sarah bought AGIO

October 26, 2026 · Form 4 insider transaction

Gheuens Sarah bought 7,866 shares of Agios Pharmaceuticals, Inc. at $25.01 per share, a transaction worth $196.7K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
7,866
Price
$25.01
Total value
$196.7K
Role—
SecurityCommon stock
Transaction codeM: Option exercise
Transaction dateOctober 26, 2026
Filing dateOctober 28, 2026
Shares owned after62,511
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR